Home > Boards > US Listed > Biotechs > Alimera Sciences (ALIM)

Alimera Sciences, In (ALIM)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
mick Member Profile
Member Level 
Followed By 2,605
Posts 855,580
Boards Moderated 196
Alias Born 09/04/00
160x600 placeholder
Alimera Obtains Marketing Authorization for ILUVIEN® in Portugal for the Treatment of Non-Infectious Posterior Uveitis GlobeNewswire Inc. - 10/3/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:31:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:29:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:26:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:23:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2019 8:06:12 AM
Alimera Sciences Announces Top Line Revenue Expectation For the Third Quarter of 2019 GlobeNewswire Inc. - 10/2/2019 8:00:00 AM
Alimera Sciences Announces Clinical Data Featuring the Benefits of ILUVIEN® to be Presented at the American Academy of Ophth... GlobeNewswire Inc. - 10/1/2019 8:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/27/2019 4:18:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 5:42:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 5:41:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 5:39:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 5:38:24 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/17/2019 5:18:52 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/17/2019 5:14:13 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/17/2019 5:10:20 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/17/2019 5:05:46 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/17/2019 5:00:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/16/2019 5:28:38 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/16/2019 5:23:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 4:25:20 PM
Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in Benelux Cou... GlobeNewswire Inc. - 9/12/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2019 8:21:11 AM
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Managemen... GlobeNewswire Inc. - 9/5/2019 8:00:00 AM
Alimera Sciences Launches ILUVIEN® in Germany For Non-Infectious Uveitis Indication GlobeNewswire Inc. - 9/3/2019 8:00:00 AM
mick Member Level  Thursday, 08/31/17 03:41:35 PM
Re: mick post# 892
Post # of 946 
Alimera Sciences, In (ALIM)
1.4 ? 0.03 (2.19%)
Volume: 97,309 @ 3:20:21 PM EDT ET
Bid Ask Day's Range
1.39 1.4 1.37 - 1.41
ALIM Detailed Quote

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist